[
  {
    "symbol": "LLY",
    "publishedDate": "2024-01-23 01:59:00",
    "publisher": "The Motley Fool",
    "title": "Don't Be Fooled by These 3 Misleading Facts About Eli Lilly Stock",
    "image": "https://images.financialmodelingprep.com/news/dont-be-fooled-by-these-3-misleading-facts-about-20240123.jpg",
    "site": "fool.com",
    "text": "Eli Lilly has a lot of debt, but it's to help expand its manufacturing capacity. It doesn't appear to have much cash, but that's because of investments in R&D.",
    "url": "https://www.fool.com/investing/2024/01/23/3-misleading-facts-about-eli-lilly-stock/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-01-23T01:59:00-05:00",
    "date_et": "2024-01-23"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-01-23 09:45:00",
    "publisher": "The Motley Fool",
    "title": "These 2 Growth Stocks Are Brilliant Buys for the New Year",
    "image": "https://images.financialmodelingprep.com/news/these-2-growth-stocks-are-brilliant-buys-for-the-20240123.jpg",
    "site": "fool.com",
    "text": "The healthcare industry has long been a compelling space for investors to generate steady returns. DexCom is raking in profits from newly launched products, and its long-term growth story looks bright.",
    "url": "https://www.fool.com/investing/2024/01/23/these-2-growth-stocks-are-brilliant-buys-for-the/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-01-23T09:45:00-05:00",
    "date_et": "2024-01-23"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-01-23 10:00:00",
    "publisher": "PRNewsWire",
    "title": "Lilly Confirms Date and Conference Call for Fourth-Quarter 2023 Financial Results and 2024 Financial Guidance",
    "image": "https://images.financialmodelingprep.com/news/lilly-confirms-date-and-conference-call-for-fourthquarter-2023-financial-20240123.jpg",
    "site": "prnewswire.com",
    "text": "INDIANAPOLIS , Jan. 23, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its fourth-quarter 2023 financial results and 2024 financial guidance on Feb. 6, 2024. Lilly will also conduct a conference call that day with the investment community and media to further detail the company's financial performance and guidance.",
    "url": "https://www.prnewswire.com/news-releases/lilly-confirms-date-and-conference-call-for-fourth-quarter-2023-financial-results-and-2024-financial-guidance-302041266.html",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-01-23T10:00:00-05:00",
    "date_et": "2024-01-23"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-01-23 12:00:00",
    "publisher": "PRNewsWire",
    "title": "Positive Phase 1/2 Clinical Trial Data for an Investigational Gene Therapy for Genetic Hearing Loss to be Presented at the Association for Research in Otolaryngology 2024 MidWinter Meeting",
    "image": "https://images.financialmodelingprep.com/news/positive-phase-12-clinical-trial-data-for-an-investigational-20240123.jpg",
    "site": "prnewswire.com",
    "text": "Hearing restoration was observed within 30 days of a single administration of AK-OTOF in the initial AK-OTOF-101 study participant, the first to receive gene therapy in the United States for a genetic form of hearing loss AK-OTOF is a gene therapy being developed for the treatment of sensorineural hearing loss due to mutations in the otoferlin gene (OTOF) INDIANAPOLIS , Jan. 23, 2024 /PRNewswire/ -- Akouos, Inc., a wholly owned subsidiary of Eli Lilly and Company (NYSE: LLY), today announced positive initial clinical results from the Phase 1/2 AK-OTOF-101 study, which demonstrated pharmacologic hearing restoration within 30 days of AK-OTOF administration in the first participant, an individual with a decade-plus history of profound hearing loss. Results, including initial data from a second participant to receive AK-OTOF, will be presented during the Late Breaking Presidential Symposium at the 2024 Association for Research in Otolaryngology (ARO) MidWinter Meeting.",
    "url": "https://www.prnewswire.com/news-releases/positive-phase-12-clinical-trial-data-for-an-investigational-gene-therapy-for-genetic-hearing-loss-to-be-presented-at-the-association-for-research-in-otolaryngology-2024-midwinter-meeting-302042082.html",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-01-23T12:00:00-05:00",
    "date_et": "2024-01-23"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-01-23 13:06:00",
    "publisher": "Market Watch",
    "title": "Eli Lilly gene therapy allows child born deaf to hear, clinical trial shows",
    "image": "https://images.financialmodelingprep.com/news/eli-lilly-gene-therapy-allows-child-born-deaf-to-20240123.jpg",
    "site": "marketwatch.com",
    "text": "An Eli Lilly & Co. LLY, -0.47% experimental gene therapy has restored the hearing of a child who was born deaf, the pharmaceutical giant said Tuesday.",
    "url": "https://www.marketwatch.com/story/eli-lilly-gene-therapy-allows-child-born-deaf-to-hear-clinical-trial-shows-e66d55be",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-01-23T13:06:00-05:00",
    "date_et": "2024-01-23"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-01-23 18:50:35",
    "publisher": "Zacks Investment Research",
    "title": "Eli Lilly (LLY) Stock Sinks As Market Gains: Here's Why",
    "image": "https://images.financialmodelingprep.com/news/eli-lilly-lly-stock-sinks-as-market-gains-heres-20240123.jpg",
    "site": "zacks.com",
    "text": "The latest trading day saw Eli Lilly (LLY) settling at $629.68, representing a -0.19% change from its previous close.",
    "url": "https://www.zacks.com/stock/news/2214575/eli-lilly-lly-stock-sinks-as-market-gains-here-s-why?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_6-2214575",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-01-23T18:50:35-05:00",
    "date_et": "2024-01-23"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-01-24 11:47:47",
    "publisher": "Reuters",
    "title": "Lilly's Mounjaro dose in limited availability in US through next month",
    "image": "https://images.financialmodelingprep.com/news/lillys-mounjaro-dose-in-limited-availability-in-us-through-20240124.jpg",
    "site": "reuters.com",
    "text": "A dose of Eli Lilly's diabetes drug Mounjaro has limited availability through February 2024, according to the U.S. Food and Drug Administration's website, due to an increase in demand.",
    "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/lillys-mounjaro-dose-limited-availability-us-through-next-month-2024-01-24/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-01-24T11:47:47-05:00",
    "date_et": "2024-01-24"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-01-25 07:09:09",
    "publisher": "MarketBeat",
    "title": "5 top healthcare stocks for earnings growth in 2024",
    "image": "https://images.financialmodelingprep.com/news/5-top-healthcare-stocks-for-earnings-growth-in-2024-20240125.jpg",
    "site": "marketbeat.com",
    "text": "Sector components forecast to show the biggest earnings year-over-year earnings improvement include Humana Inc. NYSE: HUM, Elevance Health Inc. NYSE: ELV, Incyte Corp. NASDAQ: INCY, Insulet Corp. NASDAQ: PODD and Cigna Group NYSE: CI.",
    "url": "https://www.marketbeat.com/originals/5-top-healthcare-stocks-for-earnings-growth-in-2024/?utm_source=snapi",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-01-25T07:09:09-05:00",
    "date_et": "2024-01-25"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-01-25 08:00:00",
    "publisher": "PRNewsWire",
    "title": "Johna Norton to Retire as Lilly Executive Vice President of Global Quality",
    "image": "https://images.financialmodelingprep.com/news/johna-norton-to-retire-as-lilly-executive-vice-president-20240125.jpg",
    "site": "prnewswire.com",
    "text": "INDIANAPOLIS , Jan. 25, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that Johna Norton, executive vice president of Global Quality, will be retiring after 34 years of service with the company, effective July 31, 2024. She will continue to serve at full capacity in her role and as a member of Lilly's Executive Committee until her retirement date.",
    "url": "https://www.prnewswire.com/news-releases/johna-norton-to-retire-as-lilly-executive-vice-president-of-global-quality-302043876.html",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-01-25T08:00:00-05:00",
    "date_et": "2024-01-25"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-01-25 11:54:17",
    "publisher": "Reuters",
    "title": "British regulator clears Lilly's injection pen for weight-loss drug Mounjaro",
    "image": "https://images.financialmodelingprep.com/news/british-regulator-clears-lillys-injection-pen-for-weightloss-drug-20240125.jpg",
    "site": "reuters.com",
    "text": "Britain's drug regulator on Thursday said it approved Eli Lilly's injection pen to administer the drug Mounjaro against obesity and diabetes.",
    "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/british-regulator-clears-lillys-injection-pen-weight-loss-drug-mounjaro-2024-01-25/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-01-25T11:54:17-05:00",
    "date_et": "2024-01-25"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-01-25 13:01:15",
    "publisher": "InvestorPlace",
    "title": "5 Mega-Cap Stocks Ready to Make the Magnificent 7 a Dynamic Dozen",
    "image": "https://images.financialmodelingprep.com/news/5-megacap-stocks-ready-to-make-the-magnificent-7-20240125.jpg",
    "site": "investorplace.com",
    "text": "Stocks were rallying again Thursday, despite Tesla's (NASDAQ: TSLA ) stinker of a quarter. Even prominent Tesla bull Dan Ives of Wedbush Securities said it was a “train wreck” and criticized Elon Musk and his team for failing to “step up like adults in the room.",
    "url": "https://investorplace.com/2024/01/5-mega-cap-stocks-ready-to-make-the-magnificent-7-a-dynamic-dozen/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-01-25T13:01:15-05:00",
    "date_et": "2024-01-25"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-01-26 06:46:53",
    "publisher": "Invezz",
    "title": "El Lilly surpasses Tesla's market size: why has the biotech stock become so attractive?",
    "image": "https://images.financialmodelingprep.com/news/el-lilly-surpasses-teslas-market-size-why-has-the-20240126.jpg",
    "site": "invezz.com",
    "text": "Barely four years ago, El Lilly (NYSE:LLY) was trading at just around $130. Fast forward, the stock trades at a whopping $627, having recently rubbed a new record price above $645.",
    "url": "https://invezz.com/news/2024/01/26/el-lilly-surpasses-teslas-market-size-why-has-the-biotech-stock-become-so-attractive/?utm_source=snapi",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-01-26T06:46:53-05:00",
    "date_et": "2024-01-26"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-01-26 15:57:19",
    "publisher": "InvestorPlace",
    "title": "3 Biotech Stocks with Potential for Major Medical Breakthroughs in 2024",
    "image": "https://images.financialmodelingprep.com/news/3-biotech-stocks-with-potential-for-major-medical-breakthroughs-20240126.png",
    "site": "investorplace.com",
    "text": "After being mostly down over the past three years, the biotech sector rallied hard to end 2023. The SPDR S&P Biotech ETF (NYSEARCA: XBI ) is up 31% in the last three months.",
    "url": "https://investorplace.com/2024/01/biotech-breakthroughs-in-2024-and-the-3-stocks-that-can-benefit/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-01-26T15:57:19-05:00",
    "date_et": "2024-01-26"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-01-26 16:12:38",
    "publisher": "Investors Business Daily",
    "title": "Short Moves In Eli Lilly Stock Good For Swing Trading",
    "image": "https://images.financialmodelingprep.com/news/short-moves-in-eli-lilly-stock-good-for-swing-trading-20240126.jpg",
    "site": "investors.com",
    "text": "Eli Lilly stock was great to own during the pullback at the beginning of the year. It might be again.",
    "url": "https://www.investors.com/research/swing-trading/short-moves-in-eli-lilly-stock-good-for-swing-trading/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-01-26T16:12:38-05:00",
    "date_et": "2024-01-26"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-01-27 08:25:00",
    "publisher": "The Motley Fool",
    "title": "Could Eli Lilly Be a Trillion-Dollar Company by 2030?",
    "image": "https://images.financialmodelingprep.com/news/could-eli-lilly-be-a-trilliondollar-company-by-2030-20240127.jpg",
    "site": "fool.com",
    "text": "Eli Lilly's valuation has soared over the last year given the blockbuster success of treatments such as Mounjaro and Verzenio. The company has other opportunities, including plaque psoriasis and psoriatic arthritis treatments, and potentially capturing part of the Alzheimer's market.",
    "url": "https://www.fool.com/investing/2024/01/27/could-eli-lilly-be-a-trillion-dollar-company-by-20/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-01-27T08:25:00-05:00",
    "date_et": "2024-01-27"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-01-29 05:15:00",
    "publisher": "The Motley Fool",
    "title": "Want to Get Richer in 2024? 2 Top Stocks to Buy Now",
    "image": "https://images.financialmodelingprep.com/news/want-to-get-richer-in-2024-2-top-stocks-20240129.jpg",
    "site": "fool.com",
    "text": "Costco Wholesale is beloved by its members and its shareholders. A healthcare titan is changing lives while delivering fortune-building returns to its investors along the way.",
    "url": "https://www.fool.com/investing/2024/01/29/want-to-get-richer-in-2024-2-top-stocks-to-buy-now/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-01-29T05:15:00-05:00",
    "date_et": "2024-01-29"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-01-29 06:26:00",
    "publisher": "The Motley Fool",
    "title": "Better Buy in 2024: The \"Magnificent Seven\" or the \"Terrific 10\"?",
    "image": "https://images.financialmodelingprep.com/news/better-buy-in-2024-the-magnificent-seven-or-the-20240129.jpg",
    "site": "fool.com",
    "text": "There's lucrative growth in the healthcare segment. The largest financial companies are no longer big banks.",
    "url": "https://www.fool.com/investing/2024/01/29/better-buy-the-magnificent-seven-or-terrific-ten/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-01-29T06:26:00-05:00",
    "date_et": "2024-01-29"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-01-29 11:25:59",
    "publisher": "Invezz",
    "title": "Eli Lilly in ‘good dialogue' with Germany on weight-loss drug coverage",
    "image": "https://images.financialmodelingprep.com/news/eli-lilly-in-good-dialogue-with-germany-on-weightloss-20240129.jpg",
    "site": "invezz.com",
    "text": "Eli Lilly & Co (NYSE: LLY) is in the green this morning following a report that it's in talks with Germany to have its weight-loss drug be included in the country's public health coverage.",
    "url": "https://invezz.com/news/2024/01/29/eli-lilly-germany-weight-loss-drug-coverage/?utm_source=snapi",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-01-29T11:25:59-05:00",
    "date_et": "2024-01-29"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-01-29 18:46:03",
    "publisher": "Zacks Investment Research",
    "title": "Eli Lilly (LLY) Beats Stock Market Upswing: What Investors Need to Know",
    "image": "https://images.financialmodelingprep.com/news/eli-lilly-lly-beats-stock-market-upswing-what-investors-20240129.jpg",
    "site": "zacks.com",
    "text": "Eli Lilly (LLY) concluded the recent trading session at $645, signifying a +0.9% move from its prior day's close.",
    "url": "https://www.zacks.com/stock/news/2217450/eli-lilly-lly-beats-stock-market-upswing-what-investors-need-to-know?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_6-2217450",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-01-29T18:46:03-05:00",
    "date_et": "2024-01-29"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-01-30 10:31:13",
    "publisher": "Zacks Investment Research",
    "title": "Is Lilly (LLY) a Buy as Wall Street Analysts Look Optimistic?",
    "image": "https://images.financialmodelingprep.com/news/is-lilly-lly-a-buy-as-wall-street-analysts-20240130.jpg",
    "site": "zacks.com",
    "text": "When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?",
    "url": "https://www.zacks.com/stock/news/2217883/is-lilly-lly-a-buy-as-wall-street-analysts-look-optimistic?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|average_broker_rating-2217883",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-01-30T10:31:13-05:00",
    "date_et": "2024-01-30"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-01-30 11:06:22",
    "publisher": "Zacks Investment Research",
    "title": "Eli Lilly (LLY) Earnings Expected to Grow: Should You Buy?",
    "image": "https://images.financialmodelingprep.com/news/eli-lilly-lly-earnings-expected-to-grow-should-you-20240130.jpg",
    "site": "zacks.com",
    "text": "Lilly (LLY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
    "url": "https://www.zacks.com/stock/news/2217983/eli-lilly-lly-earnings-expected-to-grow-should-you-buy?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_9-2217983",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-01-30T11:06:22-05:00",
    "date_et": "2024-01-30"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-01-31 06:46:12",
    "publisher": "CNBC",
    "title": "Norway's giant wealth fund touts possibility of Novo Nordisk, Eli Lilly joining the trillion-dollar club",
    "image": "https://images.financialmodelingprep.com/news/norways-giant-wealth-fund-touts-possibility-of-novo-nordisk-20240131.jpeg",
    "site": "cnbc.com",
    "text": "Norway's giant wealth fund says Novo Nordisk and Eli Lilly could be on course to become the first health care companies to join the trillion-dollar club.",
    "url": "https://www.cnbc.com/2024/01/31/norway-wealth-fund-says-novo-eli-lilly-may-join-trillion-dollar-club.html",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-01-31T06:46:12-05:00",
    "date_et": "2024-01-31"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-01-31 07:08:51",
    "publisher": "Reuters",
    "title": "As Lilly competition heats up, Novo CEO details strategy for new Wegovy launches",
    "image": "https://images.financialmodelingprep.com/news/as-lilly-competition-heats-up-novo-ceo-details-strategy-20240131.jpg",
    "site": "reuters.com",
    "text": "Novo Nordisk will target launches of its mega popular obesity shot Wegovy in markets where it already has strong sales of its older weight-loss drug Saxenda, CEO Lars Fruergaard Jorgensen said, as it faces growing competition from U.S. rival Eli Lilly.",
    "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/lilly-competition-heats-up-novo-ceo-details-strategy-new-wegovy-launches-2024-01-31/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-01-31T07:08:51-05:00",
    "date_et": "2024-01-31"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-01-31 10:01:12",
    "publisher": "Zacks Investment Research",
    "title": "Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It",
    "image": "https://images.financialmodelingprep.com/news/eli-lilly-and-company-lly-is-a-trending-stock-20240131.jpg",
    "site": "zacks.com",
    "text": "Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
    "url": "https://www.zacks.com/stock/news/2218601/eli-lilly-and-company-lly-is-a-trending-stock-facts-to-know-before-betting-on-it?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|most_searched_stocks-2218601",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-01-31T10:01:12-05:00",
    "date_et": "2024-01-31"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-01-31 12:03:34",
    "publisher": "InvestorPlace",
    "title": "Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for January 2024",
    "image": "https://images.financialmodelingprep.com/news/wall-street-favorites-3-biotech-stocks-with-strong-buy-20240131.jpg",
    "site": "investorplace.com",
    "text": "There is a lot of good news to digest from the biotech sector. Not only does it offer lots of strong stocks in January, but it is also expected to grow rapidly.",
    "url": "https://investorplace.com/2024/01/wall-street-favorites-3-biotech-stocks-with-strong-buy-ratings-for-january-2024/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-01-31T12:03:34-05:00",
    "date_et": "2024-01-31"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-01-31 18:16:00",
    "publisher": "The Motley Fool",
    "title": "Why Eli Lilly Stock Topped the Market Today",
    "image": "https://images.financialmodelingprep.com/news/why-eli-lilly-stock-topped-the-market-today-20240131.jpg",
    "site": "fool.com",
    "text": "A rival posted highly encouraging annual results for 2023. A great deal of its growth was due to a certain category of medications Eli Lilly also has in its product lineup.",
    "url": "https://www.fool.com/investing/2024/01/31/why-eli-lilly-stock-topped-the-market-today/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-01-31T18:16:00-05:00",
    "date_et": "2024-01-31"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-01 10:21:23",
    "publisher": "Zacks Investment Research",
    "title": "Lilly (LLY) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures",
    "image": "https://images.financialmodelingprep.com/news/lilly-lly-q4-earnings-on-the-horizon-analysts-insights-20240201.jpg",
    "site": "zacks.com",
    "text": "Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Lilly (LLY), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2023.",
    "url": "https://www.zacks.com/stock/news/2219391/lilly-lly-q4-earnings-on-the-horizon-analysts-insights-on-key-performance-measures?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|nfm_preview-2219391",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-01T10:21:23-05:00",
    "date_et": "2024-02-01"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-02 09:51:26",
    "publisher": "Zacks Investment Research",
    "title": "4 Large Drug Stocks Trying to Survive the Industry Challenges",
    "image": "https://images.financialmodelingprep.com/news/4-large-drug-stocks-trying-to-survive-the-industry-20240202.jpg",
    "site": "zacks.com",
    "text": "Drug and biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), AbbVie (ABBV) and Novartis (NVS) are worth retaining in one's portfolio.",
    "url": "https://www.zacks.com/commentary/2220023/4-large-drug-stocks-trying-to-survive-the-industry-challenges?cid=CS-STOCKNEWSAPI-FT-industry_outlook-2220023",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-02T09:51:26-05:00",
    "date_et": "2024-02-02"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-02 14:39:14",
    "publisher": "InvestorPlace",
    "title": "3 Pharma Stocks to Sell in February Before They Crash and Burn",
    "image": "https://images.financialmodelingprep.com/news/3-pharma-stocks-to-sell-in-february-before-they-20240202.jpg",
    "site": "investorplace.com",
    "text": "The pharma industry has developed some real blockbusters between novel vaccines and weight loss drugs over the past few years. This has increasingly led investors to view pharma stocks as a promising growth industry after years of underperformance, but many are top pharma stocks to sell.",
    "url": "https://investorplace.com/2024/02/3-pharma-stocks-to-sell-in-february-before-they-crash-and-burn/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-02T14:39:14-05:00",
    "date_et": "2024-02-02"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-04 04:05:00",
    "publisher": "The Motley Fool",
    "title": "After a 90% Gain, Is It Too Late to Buy Eli Lilly?",
    "image": "https://images.financialmodelingprep.com/news/after-a-90-gain-is-it-too-late-to-buy-20240204.jpg",
    "site": "fool.com",
    "text": "Eli Lilly is a leader in one of the fastest-growing pharmaceutical segments today: the weight-loss market. The company recently released a new treatment specifically approved for weight management.",
    "url": "https://www.fool.com/investing/2024/02/04/after-a-90-gain-is-it-too-late-to-buy-eli-lilly/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-04T04:05:00-05:00",
    "date_et": "2024-02-04"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-04 14:00:00",
    "publisher": "Barrons",
    "title": "Disney, Uber, Eli Lilly, PayPal, Alibaba, and More Stocks",
    "image": "https://images.financialmodelingprep.com/news/disney-uber-eli-lilly-paypal-alibaba-and-more-stocks-20240204.jpg",
    "site": "barrons.com",
    "text": "Around 100 S&P 500 companies will report fourth-quarter results. Plus, annual revisions to the consumer price index and the Services PMI.",
    "url": "https://www.barrons.com/articles/stocks-to-watch-disney-uber-eli-lilly-paypal-alibaba-ford-2cbab039",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-04T14:00:00-05:00",
    "date_et": "2024-02-04"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-05 09:36:07",
    "publisher": "Reuters",
    "title": "FDA website shows limited availability of some doses of Lilly's Mounjaro",
    "image": "https://images.financialmodelingprep.com/news/fda-website-shows-limited-availability-of-some-doses-of-20240205.jpg",
    "site": "reuters.com",
    "text": "The U.S. Food and Drug Administration's website said some doses of Eli Lilly's diabetes drug Mounjaro are available only in limited quantities through early March 2024.",
    "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/fda-website-shows-limited-availability-some-doses-lillys-mounjaro-2024-02-05/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-05T09:36:07-05:00",
    "date_et": "2024-02-05"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-05 10:15:00",
    "publisher": "The Motley Fool",
    "title": "Is It Too Late to Buy Eli Lilly Stock?",
    "image": "https://images.financialmodelingprep.com/news/is-it-too-late-to-buy-eli-lilly-stock-20240205.jpg",
    "site": "fool.com",
    "text": "Eli Lilly has new bestselling medicines, and more in development. However, its shares have been bid up to trade at a high valuation.",
    "url": "https://www.fool.com/investing/2024/02/05/is-it-too-late-to-buy-eli-lilly-stock/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-05T10:15:00-05:00",
    "date_et": "2024-02-05"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-05 11:17:04",
    "publisher": "MarketBeat",
    "title": "Markets suddenly price Eli Lilly stock for a breakout on earnings",
    "image": "https://images.financialmodelingprep.com/news/markets-suddenly-price-eli-lilly-stock-for-a-breakout-20240205.jpg",
    "site": "marketbeat.com",
    "text": "Nowadays, the market sends mixed signals to virtually every investor attempting to participate today, squeezing out a few percentage points of gains from the stock movements. With the Federal Reserve (Fed) proposing interest rate cuts this year and a FedWatch tool at the CME Group NYSE: CME now pushing the probability of them happening by May of this year, there are a lot of itchy fingers today.",
    "url": "https://www.marketbeat.com/originals/markets-suddenly-price-eli-lilly-stock-for-a-breakout-on-earnings/?utm_source=snapi",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-05T11:17:04-05:00",
    "date_et": "2024-02-05"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-05 13:08:13",
    "publisher": "Investors Business Daily",
    "title": "Amgen Is Trying To Take On Lilly, Novo In Obesity Treatment — Here's Why Lilly Stock Just Hit A Record",
    "image": "https://images.financialmodelingprep.com/news/amgen-is-trying-to-take-on-lilly-novo-in-20240205.jpg",
    "site": "investors.com",
    "text": "Amgen stock slumped Monday — as Eli Lilly stock hit a record high — after the company unveiled preclinical results for its weight-loss drug.",
    "url": "https://www.investors.com/news/technology/amgen-stock-slumps-as-it-looks-to-take-on-weight-loss-drugs-leaders-lilly-novo/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-05T13:08:13-05:00",
    "date_et": "2024-02-05"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-05 14:18:07",
    "publisher": "InvestorPlace",
    "title": "NVO, LLY or AZN: Which Pharma Stock Is the Best Weight-Loss Investment?",
    "image": "https://images.financialmodelingprep.com/news/nvo-lly-or-azn-which-pharma-stock-is-the-20240205.png",
    "site": "investorplace.com",
    "text": "Artificial intelligence grabbed most of the headlines last year, but weight loss stocks were equally noteworthy. It grew slowly for several years but really went stratospheric last year.",
    "url": "https://investorplace.com/2024/02/nvo-lly-or-azn-which-pharma-stock-is-the-best-weight-loss-investment/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-05T14:18:07-05:00",
    "date_et": "2024-02-05"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-05 16:14:41",
    "publisher": "InvestorPlace",
    "title": "3 High-Octane Growth Stocks Not Slowing Down Any Time Soon",
    "image": "https://images.financialmodelingprep.com/news/3-highoctane-growth-stocks-not-slowing-down-any-time-20240205.jpg",
    "site": "investorplace.com",
    "text": "When finding stocks to own, growth stocks are a top priority. For those looking to invest with a truly long-term investing time horizon, growth stocks tend to outperform.",
    "url": "https://investorplace.com/2024/02/3-high-octane-growth-stocks-not-slowing-down-any-time-soon/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-05T16:14:41-05:00",
    "date_et": "2024-02-05"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-06 06:45:00",
    "publisher": "PRNewsWire",
    "title": "Lilly Reports Strong Fourth-Quarter 2023 Financial Results and Provides 2024 Guidance",
    "image": "https://images.financialmodelingprep.com/news/lilly-reports-strong-fourthquarter-2023-financial-results-and-provides-20240206.jpg",
    "site": "prnewswire.com",
    "text": "Revenue in Q4 2023 increased 28%. New Products(i) revenue grew by $2.19 billion to $2.49 billion in Q4 2023, led by Mounjaro and Zepbound.",
    "url": "https://www.prnewswire.com/news-releases/lilly-reports-strong-fourth-quarter-2023-financial-results-and-provides-2024-guidance-302053915.html",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-06T06:45:00-05:00",
    "date_et": "2024-02-06"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-06 06:50:27",
    "publisher": "Reuters",
    "title": "Lilly sees 2024 profit above estimates on strong demand for weight-loss drug",
    "image": "https://images.financialmodelingprep.com/news/lilly-sees-2024-profit-above-estimates-on-strong-demand-20240206.jpg",
    "site": "reuters.com",
    "text": "Eli Lilly forecast 2024 profit above Wall Street estimates on Tuesday, driven by demand for its recently approved weight-loss drug Zepbound and diabetes medicine Mounjaro, both known chemically as tirzepatide.",
    "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/lilly-sees-2024-profit-above-estimates-strong-demand-weight-loss-drug-2024-02-06/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-06T06:50:27-05:00",
    "date_et": "2024-02-06"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-06 06:56:03",
    "publisher": "CNBC",
    "title": "Eli Lilly results blow past estimates on strong Zepbound launch, higher Mounjaro prices",
    "image": "https://images.financialmodelingprep.com/news/eli-lilly-results-blow-past-estimates-on-strong-zepbound-20240206.jpeg",
    "site": "cnbc.com",
    "text": "The quarterly results are the first to include sales of Eli Lilly's new weight loss drug Zepbound, which won FDA approval in early November.",
    "url": "https://www.cnbc.com/2024/02/06/eli-lilly-lly-earnings-q4-2023.html",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-06T06:56:03-05:00",
    "date_et": "2024-02-06"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-06 07:02:45",
    "publisher": "Invezz",
    "title": "Eli Lilly beats Q4 estimates on solid demand for weight-loss drug",
    "image": "https://images.financialmodelingprep.com/news/eli-lilly-beats-q4-estimates-on-solid-demand-for-20240206.jpg",
    "site": "invezz.com",
    "text": "Eli Lilly & Co (NYSE: LLY) is trading up in premarket on Tuesday after coming in ahead of Street estimates in its fiscal fourth quarter on a solid launch of Zepbound (weight-loss drug) and higher prices for Mounjaro (diabetes drugs). Investors are pleased also because the management issued upbeat guidance for the future.",
    "url": "https://invezz.com/news/2024/02/06/eli-lilly-q4-earnings-release/?utm_source=snapi",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-06T07:02:45-05:00",
    "date_et": "2024-02-06"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-06 07:03:00",
    "publisher": "Market Watch",
    "title": "Eli Lilly's stock surges toward a 5th straight record after an earnings beat and upbeat outlook",
    "image": "https://images.financialmodelingprep.com/news/eli-lillys-stock-surges-toward-a-5th-straight-record-20240206.jpg",
    "site": "marketwatch.com",
    "text": "Shares of Eli Lilly and Co. LLY, +5.77% rallied toward a fifth-straight record close in premarket trading Tuesday, after the drug maker's fourth-quarter earnings beat expectations, helped by a 16% jump in prices, and provided an upbeat 2024 revenue outlook. Net income rose to $2.19 billion, or $2.42 a share, from $1.94 billion, or $2.14 a share, in the year-ago period.",
    "url": "https://www.marketwatch.com/story/eli-lillys-stock-surges-toward-a-5th-straight-record-after-an-earnings-beat-and-upbeat-outlook-5a298405",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-06T07:03:00-05:00",
    "date_et": "2024-02-06"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-06 07:07:09",
    "publisher": "Proactive Investors",
    "title": "Dow seen slightly lower but Eli Lilly jumps on earnings beat",
    "image": "https://images.financialmodelingprep.com/news/dow-seen-slightly-lower-but-eli-lilly-jumps-on-20240206.jpg",
    "site": "proactiveinvestors.com",
    "text": "7:00am: Modest falls expected; Eli Lilly jumps on earnings beat Stock futures in New York edged lower on Tuesday as investors braced for another busy day of corporate news. In pre-market trading, futures for the Dow Jones Industrial Average were down 0.2%, while those for the S&P 500 eased 0.1% and contracts for the Nasdaq 100 futures declined 0.1%.",
    "url": "https://www.proactiveinvestors.com/companies/news/1040285?SNAPI",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-06T07:07:09-05:00",
    "date_et": "2024-02-06"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-06 07:32:59",
    "publisher": "Investors Business Daily",
    "title": "Eli Lilly Stock Veers Higher On Fourth-Quarter Beat",
    "image": "https://images.financialmodelingprep.com/news/eli-lilly-stock-veers-higher-on-fourthquarter-beat-20240206.jpg",
    "site": "investors.com",
    "text": "Eli Lilly Scored a strong Q4 win and provided healthy guidance Tuesday. Shares moved toward a profit-taking zone following a January breakout.",
    "url": "https://www.investors.com/news/technology/eli-lilly-stock-eli-lilly-earnings-q4-2023/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-06T07:32:59-05:00",
    "date_et": "2024-02-06"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-06 07:41:44",
    "publisher": "Forbes",
    "title": "Zepbound Maker Eli Lilly Forecasts Strong Profits Amid Rollout Of Weight Loss Drug",
    "image": "https://images.financialmodelingprep.com/news/zepbound-maker-eli-lilly-forecasts-strong-profits-amid-rollout-20240206.jpg",
    "site": "forbes.com",
    "text": "Eli Lilly shares jumped in premarket Tuesday after the company reported better-than-expected fourth quarter results and revised its 2024 forecast ahead of expectations, amid soaring demand for its diabetes drug Mounjaro and newly-approved weight loss drug Zepbound.",
    "url": "https://www.forbes.com/sites/roberthart/2024/02/06/zepbound-maker-eli-lilly-forecasts-strong-profits-amid-rollout-of-weight-loss-drug/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-06T07:41:44-05:00",
    "date_et": "2024-02-06"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-06 08:55:16",
    "publisher": "Zacks Investment Research",
    "title": "Eli Lilly (LLY) Tops Q4 Earnings and Revenue Estimates",
    "image": "https://images.financialmodelingprep.com/news/eli-lilly-lly-tops-q4-earnings-and-revenue-estimates-20240206.jpg",
    "site": "zacks.com",
    "text": "Eli Lilly (LLY) came out with quarterly earnings of $2.49 per share, beating the Zacks Consensus Estimate of $2.47 per share. This compares to earnings of $2.09 per share a year ago.",
    "url": "https://www.zacks.com/stock/news/2221562/eli-lilly-lly-tops-q4-earnings-and-revenue-estimates?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_4-2221562",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-06T08:55:16-05:00",
    "date_et": "2024-02-06"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-06 10:30:39",
    "publisher": "Forbes",
    "title": "Tesla Now Worth $110 Billion Less Than Weight Loss Drug Maker Eli Lilly",
    "image": "https://images.financialmodelingprep.com/news/tesla-now-worth-110-billion-less-than-weight-loss-20240206.jpg",
    "site": "forbes.com",
    "text": "Out with electric vehicles, in with weight loss drugs: Investors have ditched one-time favorite Tesla for pharmaceutical giant Eli Lilly, as the early days of long-established Eli Lilly's diabetes and weight loss drugs deliver explosive profits.",
    "url": "https://www.forbes.com/sites/dereksaul/2024/02/06/tesla-now-worth-110-billion-less-than-weight-loss-drug-maker-eli-lilly/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-06T10:30:39-05:00",
    "date_et": "2024-02-06"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-06 10:46:36",
    "publisher": "Proactive Investors",
    "title": "Eli Lilly buoyed by demand for new weight loss drug",
    "image": "https://images.financialmodelingprep.com/news/eli-lilly-buoyed-by-demand-for-new-weight-loss-20240206.jpg",
    "site": "proactiveinvestors.com",
    "text": "Pharma giant Eli Lilly and Co said expects revenues to grow by 18% in 2024 to more than $40 billion with the surge is attributed to the growing demand for its diabetes and obesity treatments, Mounjaro and Zepbound. The latter, an injectable weight-loss drug, achieved $175.8 million in global sales in the last quarter after receiving FDA approval in November.",
    "url": "https://www.proactiveinvestors.com/companies/news/1040329?SNAPI",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-06T10:46:36-05:00",
    "date_et": "2024-02-06"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-06 11:41:40",
    "publisher": "The Motley Fool",
    "title": "Why Eli Lilly Stock Jumped as Much as 5.1% Today Then Gave Up Its Gains",
    "image": "https://images.financialmodelingprep.com/news/why-eli-lilly-stock-jumped-as-much-as-51-20240206.jpg",
    "site": "fool.com",
    "text": "Eli Lilly handily beat Wall Street estimates with its Q4 results. The midpoint of the company's full-year 2024 revenue guidance range also topped the average analysts' estimate.",
    "url": "https://www.fool.com/investing/2024/02/06/why-eli-lilly-stock-jumped-as-much-as-51-today/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-06T11:41:40-05:00",
    "date_et": "2024-02-06"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-06 11:46:10",
    "publisher": "Zacks Investment Research",
    "title": "Earnings, Fed Speakers Dominate Activity; Lilly Beats, Spotify Misses",
    "image": "https://images.financialmodelingprep.com/news/earnings-fed-speakers-dominate-activity-lilly-beats-spotify-misses-20240206.jpg",
    "site": "zacks.com",
    "text": "Investors of Lilly (LLY) are responding to the eye-opening efficacy of obesity drugs Mounjaro and Zepbound.",
    "url": "https://www.zacks.com/stock/news/2221907/earnings-fed-speakers-dominate-activity-lilly-beats-spotify-misses?cid=CS-STOCKNEWSAPI-FT-ahead_of_wall_street-2221907",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-06T11:46:10-05:00",
    "date_et": "2024-02-06"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-06 11:51:06",
    "publisher": "Zacks Investment Research",
    "title": "Eli Lilly (LLY) Q4 Earnings Beat, Mounjaro, Zepbound Drive Sales",
    "image": "https://images.financialmodelingprep.com/news/eli-lilly-lly-q4-earnings-beat-mounjaro-zepbound-drive-20240206.jpg",
    "site": "zacks.com",
    "text": "Eli Lilly (LLY) beats fourth-quarter estimates for earnings as well as sales. The company issues an upbeat guidance for 2024.",
    "url": "https://www.zacks.com/stock/news/2221913/eli-lilly-lly-q4-earnings-beat-mounjaro-zepbound-drive-sales?cid=CS-STOCKNEWSAPI-FT-analyst_blog|earnings_article-2221913",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-06T11:51:06-05:00",
    "date_et": "2024-02-06"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-06 12:06:01",
    "publisher": "CNBC",
    "title": "Eli Lilly says weight loss drug shows promise as treatment for fatty liver disease",
    "image": "https://images.financialmodelingprep.com/news/eli-lilly-says-weight-loss-drug-shows-promise-as-20240206.jpeg",
    "site": "cnbc.com",
    "text": "The results add to a long list of potential health benefits of tirzepatide besides helping patients shed significant pounds and regulate blood sugar.",
    "url": "https://www.cnbc.com/2024/02/06/eli-lilly-weight-loss-drug-may-treat-fatty-liver-disease.html",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-06T12:06:01-05:00",
    "date_et": "2024-02-06"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-06 12:31:03",
    "publisher": "Zacks Investment Research",
    "title": "Compared to Estimates, Lilly (LLY) Q4 Earnings: A Look at Key Metrics",
    "image": "https://images.financialmodelingprep.com/news/compared-to-estimates-lilly-lly-q4-earnings-a-look-20240206.jpg",
    "site": "zacks.com",
    "text": "While the top- and bottom-line numbers for Lilly (LLY) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.",
    "url": "https://www.zacks.com/stock/news/2221950/compared-to-estimates-lilly-lly-q4-earnings-a-look-at-key-metrics?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|nfm-2221950",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-06T12:31:03-05:00",
    "date_et": "2024-02-06"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-06 14:13:21",
    "publisher": "CNBC",
    "title": "Healthy Returns: Novo Nordisk, Eli Lilly are tackling weight loss drug supply woes",
    "image": "https://images.financialmodelingprep.com/news/healthy-returns-novo-nordisk-eli-lilly-are-tackling-weight-20240206.jpeg",
    "site": "cnbc.com",
    "text": "Novo Nordisk and Eli Lilly are working to increase supply of their popular weight loss drugs. Meanwhile, the implantable neurotechnology field is heating up.",
    "url": "https://www.cnbc.com/2024/02/06/healthy-returns-novo-nordisk-eli-lilly-tackle-weight-loss-drug-supply-woes.html",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-06T14:13:21-05:00",
    "date_et": "2024-02-06"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-06 14:48:01",
    "publisher": "InvestorPlace",
    "title": "Eli Lilly, Novo Nordisk Could Be First Trillion-Dollar Drug Stocks",
    "image": "https://images.financialmodelingprep.com/news/eli-lilly-novo-nordisk-could-be-first-trilliondollar-drug-20240206.png",
    "site": "investorplace.com",
    "text": "The trillion-dollar market valuation club is currently dominated by the tech sector. Saudi Aramco is the sole exception.",
    "url": "https://investorplace.com/2024/02/eli-lilly-novo-nordisk-could-be-first-trillion-dollar-drug-stocks/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-06T14:48:01-05:00",
    "date_et": "2024-02-06"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-06 16:47:04",
    "publisher": "Seeking Alpha",
    "title": "Eli Lilly and Co (LLY) Q4 2023 Earnings Conference Call Transcript",
    "image": "https://images.financialmodelingprep.com/news/eli-lilly-and-co-lly-q4-2023-earnings-conference-20240206.jpg",
    "site": "seekingalpha.com",
    "text": "Eli Lilly and Co (LLY) Q4 2023 Earnings Conference Call Transcript",
    "url": "https://seekingalpha.com/article/4667960-eli-lilly-and-co-lly-q4-2023-earnings-conference-call-transcript",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-06T16:47:04-05:00",
    "date_et": "2024-02-06"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-07 10:23:11",
    "publisher": "Reuters",
    "title": "Eli Lilly settles Minnesota lawsuit over insulin pricing",
    "image": "https://images.financialmodelingprep.com/news/eli-lilly-settles-minnesota-lawsuit-over-insulin-pricing-20240207.jpg",
    "site": "reuters.com",
    "text": "Eli Lilly has settled a lawsuit by Minnesota that accused the three largest insulin makers of deceptively raising the price of insulin, which is used to treat diabetes.",
    "url": "https://www.reuters.com/legal/eli-lilly-settles-minnesota-lawsuit-over-insulin-pricing-2024-02-07/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-07T10:23:11-05:00",
    "date_et": "2024-02-07"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-07 11:06:05",
    "publisher": "Zacks Investment Research",
    "title": "ETFs to Buy as Mounjaro Powers Eli Lilly's Q4 Earnings Beat",
    "image": "https://images.financialmodelingprep.com/news/etfs-to-buy-as-mounjaro-powers-eli-lillys-q4-20240207.jpg",
    "site": "zacks.com",
    "text": "Eli Lilly and Company (LLY) posted robust fourth-quarter 2023 earnings, beating estimates on both the top and bottom lines driven by strong sales of its diabetes and weight-loss treatments.",
    "url": "https://www.zacks.com/stock/news/2222669/etfs-to-buy-as-mounjaro-powers-eli-lilly-s-q4-earnings-beat?cid=CS-STOCKNEWSAPI-FT-etf_news_and_commentary-2222669",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-07T11:06:05-05:00",
    "date_et": "2024-02-07"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-07 15:48:00",
    "publisher": "Barrons",
    "title": "Liver Disease Biotechs Dive on Eli Lilly Data",
    "image": "https://images.financialmodelingprep.com/news/liver-disease-biotechs-dive-on-eli-lilly-data-20240207.jpg",
    "site": "barrons.com",
    "text": "MASH is an advanced liver disorder that can lead to cancer or liver failure.",
    "url": "https://www.barrons.com/articles/eli-lilly-stock-mounjaro-liver-disease-mash-63d06fc1",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-07T15:48:00-05:00",
    "date_et": "2024-02-07"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-07 16:43:25",
    "publisher": "Forbes",
    "title": "Eli Lilly Agrees To Donate Insulin To Clinics Across Minnesota In Lawsuit Settlement",
    "image": "https://images.financialmodelingprep.com/news/eli-lilly-agrees-to-donate-insulin-to-clinics-across-20240207.jpg",
    "site": "forbes.com",
    "text": "Minnesota Attorney General Keith Ellison announced Wednesday that pharmaceutical giant Eli Lilly will donate insulin to clinics around the state for the next five years—and keep a $35 price cap for all patients in the state—to settle allegations that it “deceptively priced” its insulin products, brought by the state in a 2018 lawsuit.",
    "url": "https://www.forbes.com/sites/caileygleeson/2024/02/07/eli-lilly-agrees-to-donate-insulin-to-clinics-across-minnesota-in-lawsuit-settlement/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-07T16:43:25-05:00",
    "date_et": "2024-02-07"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-07 19:01:55",
    "publisher": "CNBC",
    "title": "Jim Cramer says recent moves in Apple, Chipotle and Eli Lilly shares don't make sense",
    "image": "https://images.financialmodelingprep.com/news/jim-cramer-says-recent-moves-in-apple-chipotle-and-20240207.jpg",
    "site": "cnbc.com",
    "text": "\"When you see some action that doesn't make sense, keep in mind that authentic stupidity is a perfectly plausible explanation,\" CNBC's Jim Cramer said.",
    "url": "https://www.cnbc.com/2024/02/07/cramer-moves-in-apple-chipotle-and-eli-lilly-shares-dont-make-sense.html",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-07T19:01:55-05:00",
    "date_et": "2024-02-07"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-08 05:50:00",
    "publisher": "The Motley Fool",
    "title": "4 Reasons Why 2024 Could Be Eli Lilly's Worst Year for the Rest of This Decade",
    "image": "https://images.financialmodelingprep.com/news/4-reasons-why-2024-could-be-eli-lillys-worst-20240208.jpg",
    "site": "fool.com",
    "text": "Two of Lilly's top-selling drugs could face challenges this year. Many patients won't have access to the company's biggest growth driver of the future.",
    "url": "https://www.fool.com/investing/2024/02/08/4-reasons-why-2024-could-be-eli-lillys-worst-year/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-08T05:50:00-05:00",
    "date_et": "2024-02-08"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-08 10:40:30",
    "publisher": "Investors Business Daily",
    "title": "Viking Therapeutics Charges To A Record High On An Update For Its Eli Lilly-Rivaling Obesity Drug",
    "image": "https://images.financialmodelingprep.com/news/viking-therapeutics-charges-to-a-record-high-on-an-20240208.jpg",
    "site": "investors.com",
    "text": "Viking Therapeutics moved up its timeline for an Eli Lilly-rivaling obesity treatment on Thursday, leading VKTX stock to a record high.",
    "url": "https://www.investors.com/news/technology/vktx-stock-charges-to-a-record-high-on-an-update-for-its-lilly-rivaling-obesity-treatment/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-08T10:40:30-05:00",
    "date_et": "2024-02-08"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-08 16:56:00",
    "publisher": "The Motley Fool",
    "title": "Here's Why Merck, Eli Lilly, and Novo Nordisk Stocks Rose 11% Last Month",
    "image": "https://images.financialmodelingprep.com/news/heres-why-merck-eli-lilly-and-novo-nordisk-stocks-20240208.jpg",
    "site": "fool.com",
    "text": "Demand is surging for weight-loss treatments that are being rolled out by major pharmaceutical companies. Investors are still trying to assess the full market opportunity and competitive landscape.",
    "url": "https://www.fool.com/investing/2024/02/08/heres-why-merck-eli-lilly-and-novo-nordisk-stocks/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-08T16:56:00-05:00",
    "date_et": "2024-02-08"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-09 07:15:00",
    "publisher": "The Motley Fool",
    "title": "Is Eli Lilly Stock a Buy Now?",
    "image": "https://images.financialmodelingprep.com/news/is-eli-lilly-stock-a-buy-now-20240209.jpg",
    "site": "fool.com",
    "text": "Diabetic medication Mounjaro is now Eli Lilly's top-selling drug. The company is projecting another year of 20% revenue growth in 2024.",
    "url": "https://www.fool.com/investing/2024/02/09/is-eli-lilly-stock-a-buy-now/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-09T07:15:00-05:00",
    "date_et": "2024-02-09"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-09 09:30:00",
    "publisher": "PRNewsWire",
    "title": "Philip Johnson to Retire as Lilly Treasurer",
    "image": "https://images.financialmodelingprep.com/news/philip-johnson-to-retire-as-lilly-treasurer-20240209.jpg",
    "site": "prnewswire.com",
    "text": "INDIANAPOLIS , Feb. 9, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) today announced that after more than 28 years, Philip Johnson, group vice president and treasurer, will retire from the company at the end of February to pursue a new professional opportunity. \"Phil has had a meaningful impact on Lilly over the last 28 years,\" said Anat Ashkenazi, executive vice president and chief financial officer at Lilly.",
    "url": "https://www.prnewswire.com/news-releases/philip-johnson-to-retire-as-lilly-treasurer-302058585.html",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-09T09:30:00-05:00",
    "date_et": "2024-02-09"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-09 12:20:31",
    "publisher": "InvestorPlace",
    "title": "3 Stocks to Sell Immediately Before the Bubble Bursts: February 2024",
    "image": "https://images.financialmodelingprep.com/news/3-stocks-to-sell-immediately-before-the-bubble-bursts-20240209.png",
    "site": "investorplace.com",
    "text": "The Federal Reserve appears set to start cutting interest rates in the coming months. That has set the bulls loose on Wall Street as traders rush to profit from the forthcoming easing in monetary policy.",
    "url": "https://investorplace.com/2024/02/3-stocks-to-sell-immediately-before-the-bubble-bursts-february-2024/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-09T12:20:31-05:00",
    "date_et": "2024-02-09"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-09 14:34:01",
    "publisher": "The Motley Fool",
    "title": "Why Shares of Eli Lilly Popped This Week",
    "image": "https://images.financialmodelingprep.com/news/why-shares-of-eli-lilly-popped-this-week-20240209.jpg",
    "site": "fool.com",
    "text": "Eli Lilly just reported strong Q4 earnings. The stock is soaring due to the growth of its weight loss drugs.",
    "url": "https://www.fool.com/investing/2024/02/09/why-shares-of-eli-lilly-popped-this-week/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-09T14:34:01-05:00",
    "date_et": "2024-02-09"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-10 06:49:00",
    "publisher": "The Motley Fool",
    "title": "3 Stocks That Could Trounce the Market in 2024",
    "image": "https://images.financialmodelingprep.com/news/3-stocks-that-could-trounce-the-market-in-2024-20240210.jpg",
    "site": "fool.com",
    "text": "Eli Lilly has major catalysts ahead. Novo Nordisk delivered strong growth in 2023 and could top that performance in 2024.",
    "url": "https://www.fool.com/investing/2024/02/10/3-stocks-that-could-trounce-the-market-in-2024/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-10T06:49:00-05:00",
    "date_et": "2024-02-10"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-10 08:00:01",
    "publisher": "CNBC",
    "title": "Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that",
    "image": "https://images.financialmodelingprep.com/news/weight-loss-drugs-are-still-hard-to-find-but-20240210.jpeg",
    "site": "cnbc.com",
    "text": "Novo Nordisk and Eli Lilly have given positive supply updates, aiming to reassure investors that they can continue to capitalize on the success of their drugs.",
    "url": "https://www.cnbc.com/2024/02/10/weight-loss-drugs-novo-nordisk-eli-lilly-are-tackling-supply-issues.html",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-10T08:00:01-05:00",
    "date_et": "2024-02-10"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-10 11:30:00",
    "publisher": "The Motley Fool",
    "title": "Eli Lilly Just Succeeded Where Others Failed, but Does It Matter for the Stock?",
    "image": "https://images.financialmodelingprep.com/news/eli-lilly-just-succeeded-where-others-failed-but-does-20240210.jpg",
    "site": "fool.com",
    "text": "A clinical trial for one of Eli Lilly's gene therapy candidates for hearing loss just reported good data. Even if it gets approved eventually, it might not make much money.",
    "url": "https://www.fool.com/investing/2024/02/10/eli-lilly-just-succeeded-where-others-failed-but-d/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-10T11:30:00-05:00",
    "date_et": "2024-02-10"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-12 05:03:00",
    "publisher": "The Motley Fool",
    "title": "Could Eli Lilly's Zepbound Become the World's Best-Selling Drug?",
    "image": "https://images.financialmodelingprep.com/news/could-eli-lillys-zepbound-become-the-worlds-bestselling-drug-20240212.jpg",
    "site": "fool.com",
    "text": "Eli Lilly's weight loss drug Zepbound generated more than $175 million in just its first few weeks on the market. The company is addressing a market that could reach $100 billion by 2030, Goldman Sachs research shows.",
    "url": "https://www.fool.com/investing/2024/02/12/could-lillys-zepbound-become-worlds-best-seller/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-12T05:03:00-05:00",
    "date_et": "2024-02-12"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-12 07:47:00",
    "publisher": "Market Watch",
    "title": "Short sellers boosted by ‘Hedge Fund Nirvana' that sees most heavily-shorted companies suffer",
    "image": "https://images.financialmodelingprep.com/news/short-sellers-boosted-by-hedge-fund-nirvana-that-sees-20240212.jpg",
    "site": "marketwatch.com",
    "text": "Hedge funds with long/short strategies have benefited in 2024 from a macroeconomic environment that has hit the most heavily shorted stocks particularly hard compared to their less shorted rivals, a new UBS report says.",
    "url": "https://www.marketwatch.com/story/short-sellers-boosted-by-hedge-fund-nirvana-that-sees-most-heavily-shorted-companies-suffer-5be59096",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-12T07:47:00-05:00",
    "date_et": "2024-02-12"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-12 08:45:00",
    "publisher": "The Motley Fool",
    "title": "This Unstoppable Growth Stock Just Announced More Good News: Is It a Buy?",
    "image": "https://images.financialmodelingprep.com/news/this-unstoppable-growth-stock-just-announced-more-good-news-20240212.jpg",
    "site": "fool.com",
    "text": "Eli Lilly's tirzepatide reported positive phase 2 results in treating a severe disease. The drugmaker may well ride the wave of tirzepatide's successes for a long time.",
    "url": "https://www.fool.com/investing/2024/02/12/this-unstoppable-growth-stock-just-announced-more/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-12T08:45:00-05:00",
    "date_et": "2024-02-12"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-12 14:01:05",
    "publisher": "Zacks Investment Research",
    "title": "A Look at Pharma ETFs After Q4 Earnings",
    "image": "https://images.financialmodelingprep.com/news/a-look-at-pharma-etfs-after-q4-earnings-20240212.jpg",
    "site": "zacks.com",
    "text": "The fourth-quarter results of the healthcare sector have been unimpressive, with earnings of companies that have reported so far down 17.7% despite 7% revenue growth. However, many industry bigwigs reported solid results, with some beating on earnings or revenues or both.",
    "url": "https://www.zacks.com/stock/news/2224986/a-look-at-pharma-etfs-after-q4-earnings?cid=CS-STOCKNEWSAPI-FT-etf_news_and_commentary-2224986",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-12T14:01:05-05:00",
    "date_et": "2024-02-12"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-13 05:50:00",
    "publisher": "The Motley Fool",
    "title": "Move Aside, Eli Lilly and Novo Nordisk. Wall Street Thinks This Stock Will Be a Bigger Winner Over the Next 12 Months.",
    "image": "https://images.financialmodelingprep.com/news/move-aside-eli-lilly-and-novo-nordisk-wall-street-20240213.jpg",
    "site": "fool.com",
    "text": "Eli Lilly and Novo Nordisk stocks have soared, thanks largely to their weight-loss drugs. However, analysts think that another big pharma stock will perform much better over the near term.",
    "url": "https://www.fool.com/investing/2024/02/13/move-aside-eli-lilly-and-novo-nordisk-wall-street/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-13T05:50:00-05:00",
    "date_et": "2024-02-13"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-13 09:17:11",
    "publisher": "Reuters",
    "title": "Eli Lilly partner BioAge raises $170 mln for obesity treatment",
    "image": "https://images.financialmodelingprep.com/news/eli-lilly-partner-bioage-raises-170-mln-for-obesity-20240213.jpg",
    "site": "reuters.com",
    "text": "BioAge Labs, a biotech startup collaborating with Eli Lilly for trialing its obesity therapy, said on Tuesday it had raised $170 million in its latest funding round.",
    "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/eli-lilly-partner-bioage-raises-170-mln-obesity-treatment-2024-02-13/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-13T09:17:11-05:00",
    "date_et": "2024-02-13"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-13 10:06:08",
    "publisher": "Zacks Investment Research",
    "title": "Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know",
    "image": "https://images.financialmodelingprep.com/news/eli-lilly-and-company-lly-is-attracting-investor-attention-20240213.jpg",
    "site": "zacks.com",
    "text": "Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.",
    "url": "https://www.zacks.com/stock/news/2225357/eli-lilly-and-company-lly-is-attracting-investor-attention-here-is-what-you-should-know?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|most_searched_stocks-2225357",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-13T10:06:08-05:00",
    "date_et": "2024-02-13"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-14 02:59:00",
    "publisher": "The Motley Fool",
    "title": "Amgen Takes Aim at Novo Nordisk and Eli Lilly, but Is the Stock a Buy?",
    "image": "https://images.financialmodelingprep.com/news/amgen-takes-aim-at-novo-nordisk-and-eli-lilly-20240214.jpg",
    "site": "fool.com",
    "text": "Amgen is the latest big pharma to join the gold rush to treat obesity. Its candidate is distinct from the medicines by Eli Lilly and Novo Nordisk.",
    "url": "https://www.fool.com/investing/2024/02/14/amgen-takes-aim-at-novo-nordisk-and-eli-lilly-but/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-14T02:59:00-05:00",
    "date_et": "2024-02-14"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-14 10:27:32",
    "publisher": "Reuters",
    "title": "Britain sees launch of Lilly's weight-loss drug Mounjaro",
    "image": "https://images.financialmodelingprep.com/news/britain-sees-launch-of-lillys-weightloss-drug-mounjaro-20240214.jpg",
    "site": "reuters.com",
    "text": "Eli Lilly's Mounjaro drug is being launched in Britain this week, two pharmacy companies said on Wednesday, making the UK the fourth European country to introduce the highly-anticipated obesity drug.",
    "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/britain-sees-launch-lillys-weight-loss-drug-mounjaro-2024-02-14/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-14T10:27:32-05:00",
    "date_et": "2024-02-14"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-14 14:43:49",
    "publisher": "InvestorPlace",
    "title": "7 Must-Buy Pharma Stocks Amid the Weight Loss Drug Revolution",
    "image": "https://images.financialmodelingprep.com/news/7-mustbuy-pharma-stocks-amid-the-weight-loss-drug-20240214.png",
    "site": "investorplace.com",
    "text": "It is entirely fair to state that weight loss treatments have massive transformational power. US FDA approval of weight loss medicines could help shrink millions of waistlines.",
    "url": "https://investorplace.com/2024/02/7-must-buy-pharma-stocks-amid-the-weight-loss-drug-revolution/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-14T14:43:49-05:00",
    "date_et": "2024-02-14"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-15 05:06:00",
    "publisher": "Market Watch",
    "title": "Tiger Global slashes stakes in Magnificent Seven while piling into semiconductor makers",
    "image": "https://images.financialmodelingprep.com/news/tiger-global-slashes-stakes-in-magnificent-seven-while-piling-20240215.jpg",
    "site": "marketwatch.com",
    "text": "Tiger Global has slashed its positions in four of the five Magnificent Seven tech stocks that account for almost half of its portfolio, while upping its stake in Amazon.com and piling into semiconductor companies, regulatory filings for the final three months of 2023 show.",
    "url": "https://www.marketwatch.com/story/tiger-global-slashes-stakes-in-magnificent-seven-while-piling-into-semiconductor-makers-0f77f27d",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-15T05:06:00-05:00",
    "date_et": "2024-02-15"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-15 09:40:01",
    "publisher": "MarketBeat",
    "title": "S&P 500's surge to new highs: Bull trap hiding in plain sight?",
    "image": "https://images.financialmodelingprep.com/news/sp-500s-surge-to-new-highs-bull-trap-hiding-20240215.jpg",
    "site": "marketbeat.com",
    "text": "The SPDR S&P 500 ETF Trust NYSEARCA: SPY is trading at new highs, but as the sharp pullback on February 13 showed, the rally may be showing signs of cracking.",
    "url": "https://www.marketbeat.com/originals/s-and-p-500s-surge-to-new-highs-bull-trap-hiding-in-plain-sight/?utm_source=snapi",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-15T09:40:01-05:00",
    "date_et": "2024-02-15"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-15 10:38:38",
    "publisher": "InvestorPlace",
    "title": "Meet the Next Trillion-Dollar Companies: Our Top 7 Picks",
    "image": "https://images.financialmodelingprep.com/news/meet-the-next-trilliondollar-companies-our-top-7-picks-20240215.png",
    "site": "investorplace.com",
    "text": "Finding the next trillion-dollar companies isn't easy, but it doesn't have to be difficult. While tempting, avoid the urge to pick a handful of small-cap tech stocks or growth stocks that you think may be worth $1 trillion or more in the future.",
    "url": "https://investorplace.com/2024/02/meet-the-next-trillion-dollar-companies-our-top-7-picks/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-15T10:38:38-05:00",
    "date_et": "2024-02-15"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-16 12:13:28",
    "publisher": "InvestorPlace",
    "title": "My Top 3 Stock Candidates to Replace Tesla in the Magnificent 7",
    "image": "https://images.financialmodelingprep.com/news/my-top-3-stock-candidates-to-replace-tesla-in-20240216.png",
    "site": "investorplace.com",
    "text": "A year ago, we wouldn't discuss replacing Tesla (NASDAQ: TSLA ) as one of the Magnificent 7 stocks. However, losing 50% of its value since November, the drum beat gets louder to replace Elon Musk's baby.",
    "url": "https://investorplace.com/2024/02/my-top-3-stock-candidates-to-replace-tesla-in-the-magnificent-7/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-16T12:13:28-05:00",
    "date_et": "2024-02-16"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-16 12:53:00",
    "publisher": "Barrons",
    "title": "Eli Lilly Stock's Upside Prompts Morgan Stanley to Ask if It Can Reach $1 Trillion",
    "image": "https://images.financialmodelingprep.com/news/eli-lilly-stocks-upside-prompts-morgan-stanley-to-ask-20240216.jpg",
    "site": "barrons.com",
    "text": "Morgan Stanley analyst Terence Flynn increases his price target on shares of the drugmaker to $950 from $805.",
    "url": "https://www.barrons.com/articles/eli-lilly-stock-trillion-market-cap-903dea31",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-16T12:53:00-05:00",
    "date_et": "2024-02-16"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-16 13:27:16",
    "publisher": "Investors Business Daily",
    "title": "Will Weight-Loss, Diabetes Drugs Drive LLY Stock Into $1 Trillion Club?",
    "image": "https://images.financialmodelingprep.com/news/will-weightloss-diabetes-drugs-drive-lly-stock-into-1-20240216.jpg",
    "site": "investors.com",
    "text": "Eli Lilly's one-two punch of weight-loss and diabetes treatments Zepbound and Mounjaro should drive the biopharma stock much higher, said a Morgan Stanley analyst.",
    "url": "https://www.investors.com/news/technology/will-weight-loss-diabetes-drugs-drive-lly-stock-into-1-trillion-club/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-16T13:27:16-05:00",
    "date_et": "2024-02-16"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-18 01:45:00",
    "publisher": "The Motley Fool",
    "title": "Where Will Eli Lilly Be in 5 Years?",
    "image": "https://images.financialmodelingprep.com/news/where-will-eli-lilly-be-in-5-years-20240218.jpg",
    "site": "fool.com",
    "text": "Its core therapeutic area will be a major tailwind in the next five years. The drugmaker should make significant progress in other fields, too.",
    "url": "https://www.fool.com/investing/2024/02/18/where-will-eli-lilly-be-in-5-years/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-18T01:45:00-05:00",
    "date_et": "2024-02-18"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-19 06:21:00",
    "publisher": "InvestorPlace",
    "title": "3 Stocks Primed to Reach Trillion-Dollar Valuation",
    "image": "https://images.financialmodelingprep.com/news/3-stocks-primed-to-reach-trilliondollar-valuation-20240219.png",
    "site": "investorplace.com",
    "text": "With the coveted trillion-dollar valuation, a new pinnacle of success is approaching for a limited number of companies. This once-impossible milestone is now within reach for three formidable potential trillion-dollar stocks.",
    "url": "https://investorplace.com/2024/02/3-stocks-primed-to-reach-trillion-dollar-valuation/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-19T06:21:00-05:00",
    "date_et": "2024-02-19"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-19 09:09:54",
    "publisher": "Reuters",
    "title": "EU drug regulator to review Lilly's Mounjaro in multi-dose pen",
    "image": "https://images.financialmodelingprep.com/news/eu-drug-regulator-to-review-lillys-mounjaro-in-multidose-20240219.jpg",
    "site": "reuters.com",
    "text": "The European Union's healthcare regulator will this week review the use of Eli Lilly's approved Mounjaro drug against diabetes and obesity when prefilled in a multi-dose injection pen, according to a meeting agenda posted on the watchdog's website on Monday.",
    "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/eu-drug-regulator-review-lillys-mounjaro-multi-dose-pen-2024-02-19/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-19T09:09:54-05:00",
    "date_et": "2024-02-19"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-19 10:15:00",
    "publisher": "The Motley Fool",
    "title": "3 Magnificent Growth Stocks to Buy Right Now",
    "image": "https://images.financialmodelingprep.com/news/3-magnificent-growth-stocks-to-buy-right-now-20240219.jpg",
    "site": "fool.com",
    "text": "AbbVie is finding ways to grow despite losing patent exclusivity for its blockbuster, Humira. Eli Lilly has delivered impressive growth over the last 12 months, and more could be on the way.",
    "url": "https://www.fool.com/investing/2024/02/19/3-magnificent-growth-stocks-to-buy-right-now/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-19T10:15:00-05:00",
    "date_et": "2024-02-19"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-20 04:28:40",
    "publisher": "Finbold",
    "title": "These stocks are overbought and may crash soon",
    "image": "https://images.financialmodelingprep.com/news/these-stocks-are-overbought-and-may-crash-soon-20240220.jpg",
    "site": "finbold.com",
    "text": "During the holiday period, stock markets experienced a lull with minimal activity. However, certain stocks garnered investor attention, pushing them into the ‘overbought' territory, potentially paving the way for a price correction.",
    "url": "https://finbold.com/these-stocks-are-overbought-and-may-crash-soon/?utm_source=snapi",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-20T04:28:40-05:00",
    "date_et": "2024-02-20"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-20 09:11:08",
    "publisher": "Zacks Investment Research",
    "title": "5 Best-Performing S&P 500 Stocks Halfway Through Q1",
    "image": "https://images.financialmodelingprep.com/news/5-bestperforming-sp-500-stocks-halfway-through-q1-20240220.jpg",
    "site": "zacks.com",
    "text": "Nvidia (NVDA), Eli Lilly (LLY), Meta Platforms (META), Uber Technologies (UBER) and Ralph Lauren (RL) are the five best-performing stocks in the S&P 500.",
    "url": "https://www.zacks.com/stock/news/2228329/5-best-performing-s-p-500-stocks-halfway-through-q1?cid=CS-STOCKNEWSAPI-FT-analyst_blog|investment_ideas-2228329",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-20T09:11:08-05:00",
    "date_et": "2024-02-20"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-20 10:00:00",
    "publisher": "PRNewsWire",
    "title": "Lilly to Participate in Cowen's 44th Annual Health Care Conference",
    "image": "https://images.financialmodelingprep.com/news/lilly-to-participate-in-cowens-44th-annual-health-care-conference-20240220.jpg",
    "site": "prnewswire.com",
    "text": "INDIANAPOLIS , Feb. 20, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in Cowen's 44th Annual Health Care Conference on March 6, 2024. Anat Ashkenazi, executive vice president and chief financial officer, will take part in a fireside chat at 9:10 a.m.",
    "url": "https://www.prnewswire.com/news-releases/lilly-to-participate-in-cowens-44th-annual-health-care-conference-302064391.html",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-20T10:00:00-05:00",
    "date_et": "2024-02-20"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-20 13:54:06",
    "publisher": "InvestorPlace",
    "title": "Top 7 Contenders to Join the Trillion-Dollar Club",
    "image": "https://images.financialmodelingprep.com/news/top-7-contenders-to-join-the-trilliondollar-club-20240220.png",
    "site": "investorplace.com",
    "text": "By hitting the elusive $3 trillion mark in valuation last month, Microsoft (NASDAQ: MSFT ) reignited the debate over trillion-dollar companies. This monumental achievement, fueled by the burgeoning artificial intelligence sector, marks a significant moment in the financial realm.",
    "url": "https://investorplace.com/2024/02/top-7-contenders-to-join-the-trillion-dollar-club/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-20T13:54:06-05:00",
    "date_et": "2024-02-20"
  },
  {
    "symbol": "LLY",
    "publishedDate": "2024-02-20 15:45:00",
    "publisher": "InvestorPlace",
    "title": "3 Top Sectors Investment Dollars Are Pouring Into Now: February 2024",
    "image": "https://images.financialmodelingprep.com/news/3-top-sectors-investment-dollars-are-pouring-into-now-20240220.png",
    "site": "investorplace.com",
    "text": "Top sectors are tough to pin down in advance. Far more often, we look backward at market performance to identify trends and top sectors.",
    "url": "https://investorplace.com/2024/02/3-top-sectors-investment-dollars-are-pouring-into-now-february-2024/",
    "ticker": "LLY",
    "event_date": "2024-02-06",
    "window_start": "2024-01-23",
    "window_end": "2024-02-20",
    "publishedDateET": "2024-02-20T15:45:00-05:00",
    "date_et": "2024-02-20"
  }
]